An animal model of human Laron syndrome [5] has been created by targeted disruption of the growth hormone receptor binding protein (GHR/BP) gene, which significantly impairs GH-mediated release of IGF-I from liver. This evidence concerns the gene IGF1 and Laron syndrome.